Cargando…
Effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial
INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is highly prevalent (~75%) in people with type 2 diabetes (T2D). Since exercise and weight loss (WL) are recommended for the management of both NAFLD and T2D, this study examined whether progressive resistance training (PRT) plus WL could lead...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557256/ https://www.ncbi.nlm.nih.gov/pubmed/36220197 http://dx.doi.org/10.1136/bmjdrc-2022-002950 |
_version_ | 1784807264791560192 |
---|---|
author | Freer, Christine L George, Elena S Tan, Sze-Yen Abbott, Gavin Dunstan, David W Daly, Robin M |
author_facet | Freer, Christine L George, Elena S Tan, Sze-Yen Abbott, Gavin Dunstan, David W Daly, Robin M |
author_sort | Freer, Christine L |
collection | PubMed |
description | INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is highly prevalent (~75%) in people with type 2 diabetes (T2D). Since exercise and weight loss (WL) are recommended for the management of both NAFLD and T2D, this study examined whether progressive resistance training (PRT) plus WL could lead to greater improvements in the fatty liver index (FLI), an indicator of NAFLD, compared with WL alone in older adults with T2D. RESEARCH DESIGN AND METHODS: This study represents a secondary analysis of a 12-month, two-arm randomised controlled trial including 36 overweight and obese adults (60–80 years) with T2D randomly allocated to supervised PRT plus WL (hypocaloric diet) (n=19) or WL plus sham (stretching) (n=17) for 6 months (phase I), followed by 6-months home-based training with ad libitum diet (phase II). FLI, which is an algorithm based on waist circumference, body mass index, triglycerides and gamma-glutamyl transferase, was assessed at baseline and every 3 months. Linear mixed models were used to analyse between-group differences over time, adjusting for baseline values. RESULTS: At baseline, the mean±SD FLI was 76.6±18.5 and the likelihood of NAFLD (FLI >60) in all participants was 86%. Following phase I, both groups had similar statistically significant improvements in FLI (mean change (95% CI): PRT+WL, −12 (−20 to –4); WL, −9 (−15 to –4)), with no significant between-group difference. After the subsequent 6-month home-based phase, the improvements in FLI tended to persist in both groups (PRT+WL, −7 (−11 to –2); WL, −4 (−10 to 1)), with no between-group differences. CONCLUSIONS: In older overweight adults with T2D, PRT did not enhance the benefits of WL on FLI, a predictor of NAFLD. TRIAL REGISTRATION NUMBER: ACTRN12622000640707. |
format | Online Article Text |
id | pubmed-9557256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-95572562022-10-14 Effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial Freer, Christine L George, Elena S Tan, Sze-Yen Abbott, Gavin Dunstan, David W Daly, Robin M BMJ Open Diabetes Res Care Cardiovascular and Metabolic Risk INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is highly prevalent (~75%) in people with type 2 diabetes (T2D). Since exercise and weight loss (WL) are recommended for the management of both NAFLD and T2D, this study examined whether progressive resistance training (PRT) plus WL could lead to greater improvements in the fatty liver index (FLI), an indicator of NAFLD, compared with WL alone in older adults with T2D. RESEARCH DESIGN AND METHODS: This study represents a secondary analysis of a 12-month, two-arm randomised controlled trial including 36 overweight and obese adults (60–80 years) with T2D randomly allocated to supervised PRT plus WL (hypocaloric diet) (n=19) or WL plus sham (stretching) (n=17) for 6 months (phase I), followed by 6-months home-based training with ad libitum diet (phase II). FLI, which is an algorithm based on waist circumference, body mass index, triglycerides and gamma-glutamyl transferase, was assessed at baseline and every 3 months. Linear mixed models were used to analyse between-group differences over time, adjusting for baseline values. RESULTS: At baseline, the mean±SD FLI was 76.6±18.5 and the likelihood of NAFLD (FLI >60) in all participants was 86%. Following phase I, both groups had similar statistically significant improvements in FLI (mean change (95% CI): PRT+WL, −12 (−20 to –4); WL, −9 (−15 to –4)), with no significant between-group difference. After the subsequent 6-month home-based phase, the improvements in FLI tended to persist in both groups (PRT+WL, −7 (−11 to –2); WL, −4 (−10 to 1)), with no between-group differences. CONCLUSIONS: In older overweight adults with T2D, PRT did not enhance the benefits of WL on FLI, a predictor of NAFLD. TRIAL REGISTRATION NUMBER: ACTRN12622000640707. BMJ Publishing Group 2022-10-11 /pmc/articles/PMC9557256/ /pubmed/36220197 http://dx.doi.org/10.1136/bmjdrc-2022-002950 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Cardiovascular and Metabolic Risk Freer, Christine L George, Elena S Tan, Sze-Yen Abbott, Gavin Dunstan, David W Daly, Robin M Effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial |
title | Effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial |
title_full | Effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial |
title_fullStr | Effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial |
title_full_unstemmed | Effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial |
title_short | Effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial |
title_sort | effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial |
topic | Cardiovascular and Metabolic Risk |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557256/ https://www.ncbi.nlm.nih.gov/pubmed/36220197 http://dx.doi.org/10.1136/bmjdrc-2022-002950 |
work_keys_str_mv | AT freerchristinel effectofprogressiveresistancetrainingwithweightlosscomparedwithweightlossaloneonthefattyliverindexinolderadultswithtype2diabetessecondaryanalysisofa12monthrandomizedcontrolledtrial AT georgeelenas effectofprogressiveresistancetrainingwithweightlosscomparedwithweightlossaloneonthefattyliverindexinolderadultswithtype2diabetessecondaryanalysisofa12monthrandomizedcontrolledtrial AT tanszeyen effectofprogressiveresistancetrainingwithweightlosscomparedwithweightlossaloneonthefattyliverindexinolderadultswithtype2diabetessecondaryanalysisofa12monthrandomizedcontrolledtrial AT abbottgavin effectofprogressiveresistancetrainingwithweightlosscomparedwithweightlossaloneonthefattyliverindexinolderadultswithtype2diabetessecondaryanalysisofa12monthrandomizedcontrolledtrial AT dunstandavidw effectofprogressiveresistancetrainingwithweightlosscomparedwithweightlossaloneonthefattyliverindexinolderadultswithtype2diabetessecondaryanalysisofa12monthrandomizedcontrolledtrial AT dalyrobinm effectofprogressiveresistancetrainingwithweightlosscomparedwithweightlossaloneonthefattyliverindexinolderadultswithtype2diabetessecondaryanalysisofa12monthrandomizedcontrolledtrial |